APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atorvastatin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Atorvastatin Market Outlook and Growth Opportunities 2026

23 December 2025193 pages

Choose your research edition.

Industry ResearchAtorvastatin Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Atorvastatin Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Atorvastatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atorvastatin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Atorvastatin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Atorvastatin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Atorvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Atorvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atorvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Atorvastatin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Atorvastatin market include Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Pfizer, Morepen, DSM Sinochem Pharmaceuticals, Combi-Blocks, Cadila Pharmaceuticals and Apotex Pharmachem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Atorvastatin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Atorvastatin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Atorvastatin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atorvastatin market size, projected growth trends, production technologies, key applications, and end-use industries.

Atorvastatin Segment by Company

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Pfizer

Morepen

DSM Sinochem Pharmaceuticals

Combi-Blocks

Cadila Pharmaceuticals

Apotex Pharmachem

Atorvastatin Segment by Type

Chemical Synthesis

Biocatalysis

Atorvastatin Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Atorvastatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Atorvastatin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Atorvastatin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Atorvastatin significant trends, drivers, influence factors in global and regions.

6. To analyze Atorvastatin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atorvastatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atorvastatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atorvastatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Atorvastatin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Atorvastatin industry.

Chapter 3: Detailed analysis of Atorvastatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Atorvastatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Atorvastatin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Atorvastatin Industry Trends Table 2. Atorvastatin Industry Drivers Table 3. Atorvastatin Industry Opportunities and Challenges Table 4. Atorvastatin Industry Restraints Table 5. Global Atorvastatin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Atorvastatin Revenue Share by Company (2021-2026) Table 7. Global Atorvastatin Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Atorvastatin Sales Volume Share by Company (2021-2026) Table 9. Global Atorvastatin Average Price (US$/ton) of Company (2021-2026) Table 10. Global Atorvastatin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Atorvastatin Key Company Manufacturing Base & Headquarters Table 12. Global Atorvastatin Company, Product Type & Application Table 13. Global Atorvastatin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Atorvastatin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Chemical Synthesis Table 18. Significant Companies of Biocatalysis Table 19. Global Atorvastatin Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 20. Global Atorvastatin Sales Volume by Type (2021-2026) & (k tons) Table 21. Global Atorvastatin Sales Volume by Type (2027-2032) & (k tons) Table 22. Global Atorvastatin Sales Volume Share by Type (2021-2026) Table 23. Global Atorvastatin Sales Volume Share by Type (2027-2032) Table 24. Global Atorvastatin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Atorvastatin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Atorvastatin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Atorvastatin Sales Value Share by Type (2021-2026) Table 28. Global Atorvastatin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacy Table 30. Significant Companies of Online Pharmacy Table 31. Significant Companies of Retail Pharmacy Table 32. Global Atorvastatin Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 33. Global Atorvastatin Sales Volume by Application (2021-2026) & (k tons) Table 34. Global Atorvastatin Sales Volume by Application (2027-2032) & (k tons) Table 35. Global Atorvastatin Sales Volume Share by Application (2021-2026) Table 36. Global Atorvastatin Sales Volume Share by Application (2027-2032) Table 37. Global Atorvastatin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Atorvastatin Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Atorvastatin Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Atorvastatin Sales Value Share by Application (2021-2026) Table 41. Global Atorvastatin Sales Value Share by Application (2027-2032) Table 42. Global Atorvastatin Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 43. Global Atorvastatin Sales by Region (2021-2026) & (k tons) Table 44. Global Atorvastatin Sales Market Share by Region (2021-2026) Table 45. Global Atorvastatin Sales by Region (2027-2032) & (k tons) Table 46. Global Atorvastatin Sales Market Share by Region (2027-2032) Table 47. Global Atorvastatin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Atorvastatin Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Atorvastatin Sales Value Share by Region (2021-2026) Table 50. Global Atorvastatin Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Atorvastatin Sales Value Share by Region (2027-2032) Table 52. Global Atorvastatin Market Average Price (US$/ton) by Region (2021-2026) Table 53. Global Atorvastatin Market Average Price (US$/ton) by Region (2027-2032) Table 54. Global Atorvastatin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 55. Global Atorvastatin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Atorvastatin Sales by Country (2021-2026) & (k tons) Table 57. Global Atorvastatin Sales Market Share by Country (2021-2026) Table 58. Global Atorvastatin Sales by Country (2027-2032) & (k tons) Table 59. Global Atorvastatin Sales Market Share by Country (2027-2032) Table 60. Global Atorvastatin Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Atorvastatin Sales Value Market Share by Country (2021-2026) Table 62. Global Atorvastatin Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Atorvastatin Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceutical Industries Company Information Table 65. Teva Pharmaceutical Industries Business Overview Table 66. Teva Pharmaceutical Industries Atorvastatin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Industries Atorvastatin Product Portfolio Table 68. Teva Pharmaceutical Industries Recent Development Table 69. Sun Pharmaceutical Industries Company Information Table 70. Sun Pharmaceutical Industries Business Overview Table 71. Sun Pharmaceutical Industries Atorvastatin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 72. Sun Pharmaceutical Industries Atorvastatin Product Portfolio Table 73. Sun Pharmaceutical Industries Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Atorvastatin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 77. Pfizer Atorvastatin Product Portfolio Table 78. Pfizer Recent Development Table 79. Morepen Company Information Table 80. Morepen Business Overview Table 81. Morepen Atorvastatin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 82. Morepen Atorvastatin Product Portfolio Table 83. Morepen Recent Development Table 84. DSM Sinochem Pharmaceuticals Company Information Table 85. DSM Sinochem Pharmaceuticals Business Overview Table 86. DSM Sinochem Pharmaceuticals Atorvastatin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 87. DSM Sinochem Pharmaceuticals Atorvastatin Product Portfolio Table 88. DSM Sinochem Pharmaceuticals Recent Development Table 89. Combi-Blocks Company Information Table 90. Combi-Blocks Business Overview Table 91. Combi-Blocks Atorvastatin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 92. Combi-Blocks Atorvastatin Product Portfolio Table 93. Combi-Blocks Recent Development Table 94. Cadila Pharmaceuticals Company Information Table 95. Cadila Pharmaceuticals Business Overview Table 96. Cadila Pharmaceuticals Atorvastatin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 97. Cadila Pharmaceuticals Atorvastatin Product Portfolio Table 98. Cadila Pharmaceuticals Recent Development Table 99. Apotex Pharmachem Company Information Table 100. Apotex Pharmachem Business Overview Table 101. Apotex Pharmachem Atorvastatin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 102. Apotex Pharmachem Atorvastatin Product Portfolio Table 103. Apotex Pharmachem Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Atorvastatin Distributors List Table 107. Atorvastatin Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Atorvastatin Product Image Figure 2. Global Atorvastatin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atorvastatin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Atorvastatin Sales (2021-2032) & (k tons) Figure 5. Global Atorvastatin Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Atorvastatin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Chemical Synthesis Image Figure 10. Biocatalysis Image Figure 11. Global Atorvastatin Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 12. Global Atorvastatin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Atorvastatin Sales Volume Share by Type (2021-2032) Figure 14. Global Atorvastatin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Atorvastatin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Atorvastatin Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Retail Pharmacy Image Figure 20. Global Atorvastatin Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 21. Global Atorvastatin Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Atorvastatin Sales Volume Share by Application (2021-2032) Figure 23. Global Atorvastatin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Atorvastatin Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Atorvastatin Sales Value Share by Application (2021-2032) Figure 26. Global Atorvastatin Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 27. Global Atorvastatin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Atorvastatin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Atorvastatin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Atorvastatin Sales Value (2021-2032) & (US$ Million) Figure 31. North America Atorvastatin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Atorvastatin Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Atorvastatin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Atorvastatin Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Atorvastatin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Atorvastatin Sales Value (2021-2032) & (US$ Million) Figure 37. South America Atorvastatin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Atorvastatin Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Atorvastatin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Atorvastatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Atorvastatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Atorvastatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Atorvastatin Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Atorvastatin Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Synthesis
  • Biocatalysis
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Pfizer
  • Morepen
  • DSM Sinochem Pharmaceuticals
  • Combi-Blocks
  • Cadila Pharmaceuticals
  • Apotex Pharmachem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atorvastatin Sales Value (2021-2032)
  4. 1.2.2 Global Atorvastatin Sales Volume (2021-2032)
  5. 1.2.3 Global Atorvastatin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Atorvastatin Market Dynamics
  1. 2.1 Atorvastatin Industry Trends
  2. 2.2 Atorvastatin Industry Drivers
  3. 2.3 Atorvastatin Industry Opportunities and Challenges
  4. 2.4 Atorvastatin Industry Restraints
3 Atorvastatin Market by Company
  1. 3.1 Global Atorvastatin Company Revenue Ranking in 2025
  2. 3.2 Global Atorvastatin Revenue by Company (2021-2026)
  3. 3.3 Global Atorvastatin Sales Volume by Company (2021-2026)
  4. 3.4 Global Atorvastatin Average Price by Company (2021-2026)
  5. 3.5 Global Atorvastatin Company Ranking (2024-2026)
  6. 3.6 Global Atorvastatin Company Manufacturing Base and Headquarters
  7. 3.7 Global Atorvastatin Company Product Type and Application
  8. 3.8 Global Atorvastatin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Atorvastatin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Atorvastatin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Atorvastatin Market by Type
  1. 4.1 Atorvastatin Type Introduction
  2. 4.1.1 Chemical Synthesis
  3. 4.1.2 Biocatalysis
  4. 4.2 Global Atorvastatin Sales Volume by Type
  5. 4.2.1 Global Atorvastatin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Atorvastatin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Atorvastatin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Atorvastatin Sales Value by Type
  9. 4.3.1 Global Atorvastatin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Atorvastatin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Atorvastatin Sales Value Share by Type (2021-2032)
5 Atorvastatin Market by Application
  1. 5.1 Atorvastatin Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Atorvastatin Sales Volume by Application
  6. 5.2.1 Global Atorvastatin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atorvastatin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Atorvastatin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Atorvastatin Sales Value by Application
  10. 5.3.1 Global Atorvastatin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Atorvastatin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Atorvastatin Sales Value Share by Application (2021-2032)
6 Atorvastatin Regional Sales and Value Analysis
  1. 6.1 Global Atorvastatin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Atorvastatin Sales by Region (2021-2032)
  3. 6.2.1 Global Atorvastatin Sales by Region: 2021-2026
  4. 6.2.2 Global Atorvastatin Sales by Region (2027-2032)
  5. 6.3 Global Atorvastatin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Atorvastatin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Atorvastatin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Atorvastatin Sales Value by Region (2027-2032)
  9. 6.5 Global Atorvastatin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Atorvastatin Sales Value (2021-2032)
  12. 6.6.2 North America Atorvastatin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Atorvastatin Sales Value (2021-2032)
  15. 6.7.2 Europe Atorvastatin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Atorvastatin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Atorvastatin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Atorvastatin Sales Value (2021-2032)
  21. 6.9.2 South America Atorvastatin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Atorvastatin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Atorvastatin Sales Value Share by Country, 2025 VS 2032
7 Atorvastatin Country-level Sales and Value Analysis
  1. 7.1 Global Atorvastatin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Atorvastatin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Atorvastatin Sales by Country (2021-2032)
  4. 7.3.1 Global Atorvastatin Sales by Country (2021-2026)
  5. 7.3.2 Global Atorvastatin Sales by Country (2027-2032)
  6. 7.4 Global Atorvastatin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Atorvastatin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Atorvastatin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Atorvastatin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Atorvastatin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Atorvastatin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Atorvastatin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Atorvastatin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Atorvastatin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Atorvastatin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Atorvastatin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Atorvastatin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Atorvastatin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Atorvastatin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Atorvastatin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Atorvastatin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Atorvastatin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Atorvastatin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Atorvastatin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Atorvastatin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Atorvastatin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Atorvastatin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Atorvastatin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Atorvastatin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Atorvastatin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Atorvastatin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Atorvastatin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Atorvastatin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Atorvastatin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Atorvastatin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Atorvastatin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Atorvastatin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Atorvastatin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Atorvastatin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Atorvastatin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Atorvastatin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Atorvastatin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Atorvastatin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Atorvastatin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Atorvastatin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Atorvastatin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Atorvastatin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Atorvastatin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Atorvastatin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Atorvastatin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Atorvastatin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Atorvastatin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Atorvastatin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Atorvastatin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Atorvastatin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Atorvastatin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Atorvastatin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Atorvastatin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Atorvastatin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Atorvastatin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Atorvastatin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Atorvastatin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Atorvastatin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Atorvastatin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Atorvastatin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Atorvastatin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Atorvastatin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Atorvastatin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Atorvastatin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Atorvastatin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Atorvastatin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Atorvastatin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Atorvastatin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Atorvastatin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Atorvastatin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Atorvastatin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Atorvastatin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Atorvastatin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Atorvastatin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Atorvastatin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Atorvastatin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Atorvastatin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Atorvastatin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Atorvastatin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Atorvastatin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Atorvastatin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Atorvastatin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Atorvastatin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Atorvastatin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Atorvastatin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Atorvastatin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Atorvastatin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Atorvastatin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Atorvastatin Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Sun Pharmaceutical Industries
  8. 8.2.1 Sun Pharmaceutical Industries Company Information
  9. 8.2.2 Sun Pharmaceutical Industries Business Overview
  10. 8.2.3 Sun Pharmaceutical Industries Atorvastatin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Industries Atorvastatin Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Industries Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Atorvastatin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Atorvastatin Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Morepen
  20. 8.4.1 Morepen Company Information
  21. 8.4.2 Morepen Business Overview
  22. 8.4.3 Morepen Atorvastatin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Morepen Atorvastatin Product Portfolio
  24. 8.4.5 Morepen Recent Developments
  25. 8.5 DSM Sinochem Pharmaceuticals
  26. 8.5.1 DSM Sinochem Pharmaceuticals Company Information
  27. 8.5.2 DSM Sinochem Pharmaceuticals Business Overview
  28. 8.5.3 DSM Sinochem Pharmaceuticals Atorvastatin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DSM Sinochem Pharmaceuticals Atorvastatin Product Portfolio
  30. 8.5.5 DSM Sinochem Pharmaceuticals Recent Developments
  31. 8.6 Combi-Blocks
  32. 8.6.1 Combi-Blocks Company Information
  33. 8.6.2 Combi-Blocks Business Overview
  34. 8.6.3 Combi-Blocks Atorvastatin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Combi-Blocks Atorvastatin Product Portfolio
  36. 8.6.5 Combi-Blocks Recent Developments
  37. 8.7 Cadila Pharmaceuticals
  38. 8.7.1 Cadila Pharmaceuticals Company Information
  39. 8.7.2 Cadila Pharmaceuticals Business Overview
  40. 8.7.3 Cadila Pharmaceuticals Atorvastatin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cadila Pharmaceuticals Atorvastatin Product Portfolio
  42. 8.7.5 Cadila Pharmaceuticals Recent Developments
  43. 8.8 Apotex Pharmachem
  44. 8.8.1 Apotex Pharmachem Company Information
  45. 8.8.2 Apotex Pharmachem Business Overview
  46. 8.8.3 Apotex Pharmachem Atorvastatin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Apotex Pharmachem Atorvastatin Product Portfolio
  48. 8.8.5 Apotex Pharmachem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Atorvastatin Value Chain Analysis
  2. 9.1.1 Atorvastatin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Atorvastatin Sales Mode & Process
  6. 9.2 Atorvastatin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Atorvastatin Distributors
  9. 9.2.3 Atorvastatin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst